Private PanOptix Pro trifocal IOL cataract surgery UK 2026

What is the AcrySof IQ Clareon PanOptix Pro trifocal IOL?

AcrySof IQ Clareon PanOptix Pro is Alcon's enhanced trifocal intra-ocular lens (IOL), implanted into the capsular bag at the time of cataract surgery or refractive lens exchange to replace the natural crystalline lens and provide a continuous functional range of vision from distance to near without spectacles. PanOptix Pro is built on the latest Clareon hydrophobic acrylic platform, a glistening-resistant biomaterial with very low surface light scatter, in contrast to the older AcrySof material used in the original PanOptix which can develop late microvacuolar glistenings. The chromophore (the natural blue-light filter) has been updated for higher overall light transmission and a milder postoperative dysphotopsia profile.

The optical design retains the proprietary ENLIGHTEN diffractive optic: a non-apodised, non-pupil-dependent diffractive grating on the posterior surface of the lens that splits incoming light between three focal points. The three add powers at the IOL plane are 2.17 D (intermediate, equivalent to ~60 cm at the spectacle plane — the typical computer screen distance) and 3.25 D (near, equivalent to ~40 cm — the typical reading distance), with distance as the third reference point. Total light transmission across the three foci is approximately 88 per cent, with the proportion of light directed to each focus relatively independent of the pupil diameter, which gives a more stable performance across day and night lighting conditions than older multifocal IOLs.

PanOptix Pro Toric (TFNT2-T9 family) is the toric variant for patients with 0.75 D or more of regular corneal astigmatism. The toric cylinder is built into the anterior surface of the IOL and is calculated on the Barrett Toric Calculator using Total Keratometry (anterior plus posterior corneal curvature) and aligned intra-operatively with image-guided platforms (Verion, Callisto eye Z Align, Cassini Ambient). The procedure is a 12 to 25 minute day-case phacoemulsification (or refractive lens exchange) under topical anaesthetic, with the IOL injected into the capsular bag through a 2.2 to 2.4 mm clear corneal incision.

UK 2026 PanOptix Pro pricing, in detail

UK 2026 PanOptix Pro pricing varies with whether the procedure is cataract surgery or refractive lens exchange, whether the toric variant is used, whether femtosecond laser-assisted cataract surgery (FLACS) is elected, the centre overhead and the seniority of the cataract and refractive consultant. The fee should be quoted as an all-inclusive per-eye package covering the cataract / refractive assessment, biometry and imaging, the day-case procedure with the PanOptix Pro IOL, intra-operative aberrometry and image-guided alignment for toric implants, and the full schedule of postoperative reviews.

For related premium IOL pricing see our private cataract surgery price guide, our Clareon Vivity EDOF guide, our toric IOL guide and our refractive lens exchange (RLE) guide.

What should be included in a private PanOptix Pro package in the UK in 2026?

• Cataract and refractive consultant — a UK GMC specialist registered consultant ophthalmologist with documented cataract and refractive fellowship, doing at least 300 to 500 phacoemulsifications a year and routine premium IOL implantation, with audit data (per cent residual refractive error within plus or minus 0.50 D, posterior capsule rupture rate, explant / exchange rate, patient-reported spectacle independence) available on request.
• Full preoperative work-up — slit-lamp, dilated examination, intraocular pressure, IOLMaster 700 swept-source optical biometry with Total Keratometry (or Argos / Galilei equivalent), Pentacam HR Scheimpflug corneal tomography (to rule out keratoconus, post-LASIK ectasia, irregular astigmatism, abnormal posterior elevation), OCT macula (to exclude macular pathology that would limit visual benefit), specular microscopy / endothelial cell count, angle kappa and angle alpha measurement (for trifocal centration safety), tear film and ocular surface assessment, dominance testing, contrast sensitivity if indicated.
• IOL power calculation — latest-generation Barrett Universal II, Barrett Toric, Hill-RBF 3.0, Kane, EVO 2.0 formulae on Total Keratometry with adjustment for posterior corneal astigmatism. Post-LASIK / post-RK eyes use a different formula set (Barrett True K, Haigis-L, ASCRS post-refractive online calculator).
• Indication confirmation — visually significant cataract or early cataract with symptomatic presbyopia, or refractive lens exchange in motivated presbyopes (especially hyperopes), after detailed counselling on dysphotopsia, neural adaptation and the realistic 80 to 90 per cent spectacle independence rate.
• Choice between PanOptix Pro and PanOptix Pro Toric — toric for 0.75 D or more of regular corneal astigmatism on Total Keratometry, calculated on the Barrett Toric Calculator and aligned intra-operatively with the Verion or Callisto eye Z Align image-guided platforms.
• Optional FLACS — femtosecond laser-assisted cataract surgery for the corneal incisions, capsulorhexis and lens fragmentation, considered for trifocal centration optimisation, high astigmatism, dense cataract, narrow pupil, weak zonules and post-LASIK eyes.
• Day-case phacoemulsification under topical anaesthetic — 2.2 to 2.4 mm clear corneal incision, capsulorhexis, hydrodissection, phacoemulsification, cortex aspiration, in-the-bag PanOptix Pro implantation, intra-operative aberrometry refinement where indicated.
• Postoperative regime — topical antibiotic for 1 to 2 weeks plus topical steroid or NSAID for 4 to 6 weeks; lubricants for 4 to 12 weeks for postoperative dry eye optimisation.
• Structured 1-day, 2-week and 6-week reviews with refraction, slit-lamp, IOP and patient-reported visual outcome.
• CQC-registered theatre with the latest report rated Good or Outstanding, transparent itemised written pricing, and direct telephone access to the consultant for 90 days postoperatively.
• Honest expectation-setting — about the 3 to 6 month neural adaptation phase, the realistic 80 to 90 per cent spectacle independence rate, the 5 to 15 per cent who use occasional reading glasses for fine print in dim light, the night-time halos and starbursts that improve but do not always disappear, and the 1 to 3 per cent who may need IOL exchange for an EDOF or aspheric monofocal lens.

What does the evidence say about PanOptix Pro?

The AcrySof IQ PanOptix and Clareon PanOptix Pro evidence base is one of the most extensive of any modern trifocal IOL:

• FDA pivotal trial of AcrySof IQ PanOptix (2019) — bilateral implantation in 129 patients showed mean uncorrected distance visual acuity 0.04 logMAR (~6/6.5), uncorrected intermediate at 60 cm 0.04 logMAR and uncorrected near at 40 cm 0.08 logMAR, with full spectacle independence in 80 to 85 per cent of bilateral patients at 6 months.
• Alcon Clareon PanOptix Pro evaluation (2023 to 2025) — updated chromophore and Clareon material show improved blue-light transmission, reduced surface light scatter and a milder dysphotopsia profile compared with the original PanOptix, with maintained visual acuity at all three focal points.
• ESCRS Functional Vision Working Group statements — trifocal IOLs (PanOptix / PanOptix Pro, AT LISA tri 839MP, FineVision Triumf, RayOne Trifocal) deliver the highest rate of full spectacle independence in well-selected patients, at the cost of mild night-time halos and a 3 to 6 month neural adaptation phase. ENLIGHTEN diffractive design (PanOptix family) gives the most favourable balance of intermediate and near performance among current trifocals.
• Royal College of Ophthalmologists Cataract Surgery Guidelines 2023 — premium IOL choice should be individualised on patient lifestyle, ocular health (macula, cornea, optic nerve), anatomy (angle kappa / alpha), residual refractive error tolerance and night-driving demands. Trifocal IOLs are appropriate in motivated patients with healthy maculae, regular corneas and realistic expectations.
• NICE NG77 Cataracts in Adults — cataract surgery indication is on functional visual impairment, not on Snellen acuity alone; NHS funds monofocal IOLs only and premium IOLs are a self-pay refractive top-up.
• UKISCRS National Ophthalmology Database (NOD) cataract audit — UK-wide cataract surgery outcome benchmarks (visual acuity, refractive error, posterior capsule rupture, endophthalmitis rate) for risk-adjusted audit comparison.
• AAO Cataract in the Adult Eye Preferred Practice Pattern — trifocal IOLs reasonable in suitable candidates with patient-aligned expectations and ocular health.
• FACT trial of femtosecond laser-assisted cataract surgery (Day et al., 2020) — FLACS and standard phacoemulsification produce equivalent visual and refractive outcomes in routine cataract surgery in experienced hands; FLACS may have specific advantages for trifocal IOL centration, high astigmatism and complex cases.
• Cost-effectiveness — for patients who would otherwise pay for high-prescription progressive spectacles, contact lenses or additional refractive procedures over their remaining lifespan, premium trifocal IOL cataract surgery is often cost-neutral or cost-saving across a 10 to 20 year horizon, while delivering full functional spectacle independence.

In short: PanOptix Pro is one of the best-evidenced trifocal IOLs in 2026, with strong randomised and real-world data on spectacle independence, predictable dysphotopsia profile and a meaningful refinement over the original PanOptix on the Clareon platform.

PanOptix Pro vs Vivity, Symfony, Synergy and monofocal IOLs

Each premium IOL category has a defined modern indication:

• PanOptix Pro / PanOptix Pro Toric (trifocal, Alcon) — three discrete focal points at distance, 60 cm intermediate and 40 cm near. Highest rate of full spectacle independence (~80 to 90 per cent bilateral). Mild-to-moderate night-time halos. Excellent for motivated cataract or RLE patients without strong night-driving demands.
• Clareon Vivity / Vivity Toric (extended depth of focus / EDOF, Alcon) — non-diffractive wavefront-shaping optic that extends the range of focus from distance to ~70 cm intermediate. Almost monofocal-quality night-time vision and contrast sensitivity. Patients typically need reading glasses for fine print at 30 to 40 cm. Best for patients who prioritise night-driving quality and minimal halos.
• Tecnis Symfony OptiBlue (EDOF, Johnson and Johnson Vision) — achromatic diffractive echelette EDOF with violet-light filter. Continuous range from distance to functional intermediate. Mild halos; better near than Vivity. Symfony OptiBlue Toric available.
• Tecnis Synergy (EDOF-trifocal hybrid, Johnson and Johnson Vision) — continuous range from distance through near, with stronger near than Symfony. Halo / glare profile sits between Symfony and PanOptix.
• FineVision Triumf / Triumf Toric (PhysIOL / BVI, trifocal-EDOF hybrid) — combines trifocal and EDOF design. Continuous range. Good performance at all distances with a measurable dysphotopsia profile similar to PanOptix.
• AT LISA tri 839MP / 939MP toric (Carl Zeiss Meditec, trifocal) — established trifocal with apodised diffractive optic. Strong distance and near, slightly weaker intermediate than PanOptix Pro.
• RayOne Trifocal / Trifocal Toric (Rayner, trifocal) — UK-manufactured trifocal with a non-pupil-dependent design. Pre-loaded delivery system. Often selected for direct comparability with NHS-style fully UK supply chain.
• Clareon aspheric monofocal / Clareon Toric / Tecnis monofocal — single focal point (usually set for distance), best night-time vision quality of any IOL category, no diffractive halos. Reading glasses needed for all near and intermediate work. Often combined with mini-monovision (one eye plano, the other -0.75 to -1.25 D) for some functional intermediate.

The decision between PanOptix Pro, an EDOF and a monofocal depends on the patient's priorities (full spectacle independence versus night-vision quality versus simplicity), ocular health (macula, cornea, optic nerve, angle kappa / alpha), refractive starting point, lifestyle and the consultant's view of suitability. The aim is to match the IOL to the patient, not the patient to the IOL.

Who is a good candidate for PanOptix Pro?

The strongest case for PanOptix Pro applies when several of the following are present:

• Visually significant cataract or early cataract with symptomatic presbyopia in a motivated patient aged ~50 to 75.
• Refractive lens exchange (RLE) candidate — high hyperope (+3 D or more) with presbyopia, or motivated presbyope unwilling to consider corneal refractive surgery, with a clear lens but established presbyopia. Eligible for clear lens extraction with PanOptix Pro on a refractive (self-pay) basis.
• Healthy macula and optic nerve — confirmed by OCT macula and dilated fundus examination; no advanced AMD, no diabetic maculopathy, no epiretinal membrane, no advanced glaucomatous field loss.
• Regular cornea — confirmed by Pentacam HR Scheimpflug tomography; no keratoconus, no post-LASIK ectasia, no pellucid marginal degeneration. Post-LASIK eyes are not absolute contra-indications but require detailed counselling and a different IOL calculation formula set, and a slightly higher residual refractive error rate.
• Regular corneal astigmatism less than 0.75 D, or 0.75 D or more corrected with PanOptix Pro Toric.
• Normal angle kappa and angle alpha (less than ~0.5 mm) for safe trifocal centration; angle kappa / alpha larger than this is associated with poorer trifocal performance and is a reason to consider an EDOF instead.
• Healthy ocular surface — treated dry eye, no significant blepharitis, no anterior basement membrane dystrophy; ocular surface optimisation is essential before biometry for an accurate trifocal calculation.
• Realistic expectations — understanding of the 80 to 90 per cent full spectacle independence rate, the 5 to 15 per cent use of occasional reading glasses, the night-time halos that may persist mildly, and the 3 to 6 month neural adaptation phase.
• Motivation for spectacle independence — the patient who has worn varifocals or contact lenses for decades and is unhappy with progressive lens distortion, or the cataract patient who specifically does not want to return to varifocals after surgery.
• No strong commercial night-driving demands — commercial pilots, long-haul truck and bus drivers, late-shift drivers are usually better served by an EDOF or monofocal.

PanOptix Pro is not usually appropriate in macular degeneration, advanced glaucoma, diabetic maculopathy, irregular cornea, post-RK eyes, abnormal angle kappa / alpha, eyes with significant pseudo-exfoliation or weak zonules at risk of IOL decentration, patients with low preoperative contrast sensitivity, professional night drivers, or patients who cannot accept any night-time halos or any 3 to 6 month adaptation phase. Suitability is always confirmed at a consultant cataract and refractive consultation.

NHS vs private PanOptix Pro in the UK 2026

NHS cataract surgery in the UK in 2026 is commissioned via NHS England (and equivalent pathways in Scotland, Wales and Northern Ireland) and is generally limited to a high-quality aspheric monofocal IOL set for distance, with reading glasses required for near work. Premium trifocal and EDOF IOLs are not part of the standard NHS commissioned cataract pathway. In a small number of NHS trusts a monofocal-plus-self-pay refractive top-up pathway is offered, where the patient pays a self-pay refractive surcharge for the trifocal or toric IOL premium and the NHS funds the cataract surgery itself; in many trusts this is not offered and the only route to a trifocal IOL is fully private. Standard NHS waits in 2026 for routine cataract surgery range from 4 to 18 weeks, with priority lists for very poor BCVA, monocular patients and falls risk.

Private PanOptix Pro is the practical route when same-month surgery matters, when you want a specific cataract and refractive subspecialty consultant with a high premium IOL volume, when you have private medical insurance that covers the cataract component, or when you specifically want premium IOL options (trifocal, EDOF, toric) not routinely offered on your local NHS pathway. Most CQC-registered London centres can complete consultation, bilateral surgery and 6-week follow-up within a 4 to 8 week window.

Does private medical insurance cover PanOptix Pro?

In 2026 the major UK private medical insurers (Bupa, AXA Health, Aviva, Vitality, WPA) cover the cataract surgery component — consultant fee, theatre time, anaesthetic, day-case stay and postoperative reviews — when a visually significant cataract is documented (BCVA worse than 6/9 in normal lighting, glare disability, posterior subcapsular cataract limiting reading or driving, or other objective functional visual impairment per NICE NG77). The premium trifocal IOL itself (and the toric premium) is treated as a self-pay refractive co-payment top-up, typically in the order of 1,000 to 2,500 pounds per eye on top of the insurance-covered cataract surgery.

Refractive lens exchange (RLE) in eyes without a visually significant cataract is a refractive procedure and is not covered by NHS or by most UK private medical insurers, regardless of the IOL chosen. The cataract clinical letter must clearly document the diagnosis, the BCVA in normal lighting, glare and contrast sensitivity findings, the impact on quality of life (driving, reading, work) and the rationale for surgery. Always pre-authorise in writing before booking, and ask for an itemised invoice that splits the cataract surgery (insurer-claimable) from the trifocal IOL premium (self-pay).

Risks and side-effects of PanOptix Pro

Cataract surgery is one of the safest surgical procedures in medicine and PanOptix Pro adds the considerations specific to a trifocal diffractive IOL. The realistic risks should be set out honestly:

• Night-time halos and starbursts (dysphotopsia) — expected with any diffractive trifocal; mild and well-tolerated in the majority by 3 to 6 months, persistently bothersome in approximately 1 to 3 per cent despite optimisation.
• Reduced contrast sensitivity in dim light — a small measurable reduction from monofocal baseline; usually not functionally limiting.
• Residual refractive error — in 5 to 15 per cent of eyes the postoperative refraction is outside plus or minus 0.50 D of target, which significantly degrades trifocal performance. Typically corrected by spectacles, top-up corneal refractive surgery (PRK or LASIK), or IOL exchange if residual error is large.
• Posterior capsular opacification (PCO) — in 10 to 30 per cent of patients by 5 years; treated with a 5-minute outpatient YAG laser capsulotomy.
• Postoperative dry eye — common in the first 3 to 6 months; treated with preservative-free lubricants, lid hygiene and warm compresses; ocular surface optimisation reduces postoperative refractive error.
• Cystoid macular oedema (Irvine-Gass) — in 1 to 5 per cent; managed with topical NSAID and steroid.
• Posterior capsular rupture — in less than 1 per cent in experienced hands; may necessitate change of IOL position (sulcus placement, scleral fixation) and rarely an alternative IOL.
• Postoperative IOP spike — transient, treated with topical or oral IOP-lowering medication.
• Endophthalmitis — very rare, less than 0.05 per cent with intracameral antibiotic cover; severe but extremely rare.
• IOL exchange — in 1 to 3 per cent of bilateral PanOptix Pro recipients for non-adaptation; feasible up to 12 to 24 months postoperatively for an EDOF or aspheric monofocal lens.
• Retinal detachment — very rare; small lifetime risk after any intra-ocular surgery, higher in young high myopes (relevant if RLE in young myopic patients).
• Need for occasional reading glasses — 5 to 15 per cent of bilateral PanOptix Pro recipients use occasional reading glasses for very fine print in dim light despite a successful operation.

The overall safety record of PanOptix Pro is excellent in experienced UK hands; the lens-specific issues (dysphotopsia, residual refractive error) are well-defined and largely managed by careful patient selection, accurate biometry, intra-operative aberrometry where indicated, ocular surface optimisation and a clear pathway for YAG capsulotomy and (rarely) IOL exchange.

What to expect after PanOptix Pro cataract surgery

• Immediately after surgery — mild blur, slight grittiness, transient light sensitivity. No bandage; a clear plastic eye shield is worn at night for the first week.
• Day 1 review — slit-lamp, IOP, refraction, IOL position. Most patients see 6/9 or better unaided in the operated eye. Topical antibiotic plus topical steroid or NSAID continued.
• Days 1 to 7 — functional vision continues to improve. Avoid swimming, eye rubbing, dusty environments and very strenuous activity. Continue topical drops as prescribed.
• 2-week review — refraction, slit-lamp, IOP. Topical antibiotic stopped; steroid or NSAID continued in a tapering regime. Bilateral surgery is normally scheduled at 1 to 4 weeks if not already done.
• 6-week refraction review — final refraction, patient-reported visual outcome at all three focal points, dysphotopsia profile, ocular surface assessment. Residual refractive error within plus or minus 0.50 D in >90 per cent of eyes.
• 3 to 6 months — neural adaptation to the trifocal optic continues; halos and starbursts soften progressively. Reading lamps with warm light, slow build-up of near-task duration, and treatment of any dry eye all help.
• 12 months — final visual outcome, patient-reported outcome (NEI VFQ-25 or similar). The IOL is a lifelong implant. Annual community optometry review thereafter.
• YAG laser capsulotomy — offered at 2 to 10 years if posterior capsular opacification develops (10 to 30 per cent), as a 5-minute outpatient laser.

How to choose a UK PanOptix Pro clinic in 2026

• Clinical leadership — a UK GMC specialist registered consultant ophthalmologist with documented cataract and refractive fellowship, doing at least 300 to 500 phacoemulsifications a year and routine premium IOL implantation, with audit data on residual refractive error, posterior capsule rupture rate, explant / exchange rate and patient-reported spectacle independence available on request.
• Full preoperative work-up — slit-lamp, IOLMaster 700 Total Keratometry biometry, Pentacam HR Scheimpflug tomography, OCT macula, specular microscopy, angle kappa / alpha, ocular surface assessment — all included in the package, not charged as add-ons.
• Latest-generation IOL calculation — Barrett Universal II, Barrett Toric, Hill-RBF 3.0, Kane, EVO 2.0; Barrett True K / ASCRS post-refractive calculator for post-LASIK and post-RK eyes.
• Intra-operative aberrometry — Alcon ORA or Cassini Ambient, particularly for post-LASIK eyes, high astigmatism, unusual axial lengths and post-vitrectomy eyes.
• Image-guided alignment for the toric variant — Verion, Callisto eye Z Align, Cassini Ambient; routine for PanOptix Pro Toric.
• FLACS option — available on request for trifocal centration optimisation, high astigmatism, dense cataract, narrow pupil, weak zonules.
• Honest evidence-based consent — written information about the 80 to 90 per cent full spectacle independence rate, the 3 to 6 month neural adaptation phase, the night-time halos and starbursts, the 1 to 3 per cent IOL exchange rate, and the 10 to 30 per cent YAG capsulotomy rate at 2 to 10 years.
• Transparent itemised pricing — the invoice should split consultation, biometry / imaging, theatre / procedure, IOL, FLACS (if elected) and postoperative reviews, so you can claim the cataract component on insurance and understand what the trifocal premium actually buys.
• CQC-registered theatre with the latest report rated Good or Outstanding.
• Same consultant throughout — consultation, surgery and all postoperative reviews done by the same cataract and refractive subspecialty consultant.
• Direct access — a published number for postoperative concerns and a same-day clinic slot if any concerning symptoms develop.

Frequently asked questions

How much does private PanOptix Pro trifocal IOL cataract surgery cost in the UK in 2026?

UK 2026 self-pay private PanOptix Pro trifocal IOL cataract surgery costs 3,800 to 5,800 pounds per eye, all-inclusive at CQC-registered London centres. RLE with PanOptix Pro and PanOptix Pro Toric for regular corneal astigmatism are typically 4,200 to 6,200 pounds per eye. The fee covers the consultant assessment, IOLMaster 700 Total Keratometry biometry, Pentacam HR Scheimpflug tomography, OCT macula, the day-case phacoemulsification with the PanOptix Pro IOL, intra-operative aberrometry where indicated, image-guided alignment for the toric variant, and 1-day / 2-week / 6-week reviews. FLACS adds 600 to 1,200 pounds per eye.

What is the difference between PanOptix Pro and the original PanOptix?

PanOptix Pro is built on the glistening-resistant Clareon hydrophobic acrylic material with an updated chromophore for improved blue-light transmission and a milder postoperative dysphotopsia profile. The optical design (ENLIGHTEN diffractive, three focal points at distance, 60 cm intermediate and 40 cm near, ~88 per cent total light transmission) is unchanged. Original PanOptix used the older AcrySof material which can develop late microvacuolar glistenings.

Will I really not need glasses after PanOptix Pro?

In well-selected bilateral PanOptix / PanOptix Pro recipients, 80 to 90 per cent report complete spectacle independence at 3 to 6 months, 5 to 15 per cent use occasional reading glasses for very fine print in dim light, and a small minority report bothersome night-time halos. Spectacle independence is highest when residual refractive error is within plus or minus 0.50 D, any clinically significant astigmatism is corrected with a toric IOL or limbal relaxing incisions, the macula and cornea are healthy and expectations are realistic.

What are the night-vision side-effects of PanOptix Pro?

All diffractive trifocal IOLs produce some night-time halos around bright lights, starbursts and rare glare, and some loss of contrast in dim light. With PanOptix Pro and the ENLIGHTEN diffractive design the dysphotopsia profile is one of the milder among trifocals, but it is real. Most patients describe halos as mild and well-tolerated by 3 to 6 months. Patients with strong night-driving demands are usually better served by an EDOF lens (Clareon Vivity, Symfony OptiBlue).

Am I a good candidate for PanOptix Pro?

Strong candidates are aged 50 to 75 with visually significant or early cataract or with high hyperopia and presbyopia (RLE), with a healthy macula and optic nerve, a regular cornea, normal angle kappa and angle alpha, regular corneal astigmatism less than 0.75 D (or toric correction), realistic expectations and no strong night-driving demands. PanOptix Pro is avoided in macular degeneration, advanced glaucoma, irregular astigmatism, post-LASIK or post-RK eyes, and patients with low preoperative contrast sensitivity.

PanOptix Pro vs Vivity, Symfony or monofocal — which is right for me?

PanOptix Pro (trifocal) maximises spectacle independence; Vivity (non-diffractive EDOF) maximises night-vision quality and contrast at the cost of needing reading glasses for fine print; Symfony OptiBlue (diffractive EDOF) sits in between; an aspheric monofocal gives the best night-vision quality and is appropriate when ocular health or lifestyle does not support a premium IOL. See our Clareon Vivity guide and our toric IOL guide.

Is PanOptix Pro covered by NHS or private medical insurance?

NHS funds monofocal IOLs only; the trifocal and toric premiums are self-pay refractive top-ups. Private medical insurers (Bupa, AXA, Aviva, Vitality, WPA) cover the cataract surgery component when a visually significant cataract is documented, but the trifocal IOL itself is a self-pay refractive co-payment. RLE in eyes without a visually significant cataract is a refractive procedure and is not covered.

What is PanOptix Pro Toric and who needs it?

PanOptix Pro Toric is the toric version of the trifocal IOL, designed for patients with 0.75 D or more of regular corneal astigmatism on Total Keratometry. Without toric correction, residual astigmatism after a trifocal IOL significantly degrades unaided distance vision and amplifies night-time halos. Toric power is calculated on the Barrett Toric Calculator using anterior plus posterior corneal curvature and aligned intra-operatively with image-guided platforms.

How long does PanOptix Pro surgery take and what is the recovery?

Phacoemulsification with PanOptix Pro takes 12 to 25 minutes per eye, day-case, under topical anaesthetic. Functional vision returns within 24 to 48 hours; trifocal neural adaptation takes 3 to 6 months. Most patients drive within 1 week of bilateral surgery, return to office work within 2 to 5 days, and resume swimming after 2 weeks. Topical antibiotic and steroid (or NSAID) drops are continued for 4 to 6 weeks.

What if I don't adapt to PanOptix Pro?

In approximately 1 to 3 per cent of bilateral PanOptix Pro recipients halos remain bothersome at 6 months despite optimisation of refractive error, ocular surface and any YAG capsulotomy. In these uncommon cases, IOL exchange for an EDOF (Clareon Vivity, Symfony OptiBlue) or aspheric monofocal lens is feasible up to 12 to 24 months postoperatively.

Should I have FLACS with my PanOptix Pro?

The FACT trial (Day et al., 2020) showed equivalent visual and refractive outcomes between FLACS and standard phacoemulsification in routine cataract surgery in experienced hands. For PanOptix Pro and PanOptix Pro Toric, FLACS gives a perfectly centred and reproducibly sized capsulorhexis (theoretically beneficial for trifocal centration) and slightly easier toric alignment. FLACS is typically recommended for high astigmatism, dense cataract, narrow pupil, weak zonules and post-LASIK eyes. UK 2026 FLACS add-on is 600 to 1,200 pounds per eye.

How long does the PanOptix Pro IOL last?

The PanOptix Pro IOL is implanted in the capsular bag and is intended to be a permanent lifelong implant. The Clareon material is glistening-resistant and stable for the life of the eye. Posterior capsular opacification (PCO) develops in 10 to 30 per cent by 5 years and is treated with a 5-minute outpatient YAG capsulotomy. There is no need to plan for a future IOL replacement in the absence of complications.

Can I have PanOptix Pro if I have had LASIK before?

Post-LASIK eyes are not absolute contra-indications but require careful counselling and a different IOL calculation formula set (Barrett True K, Haigis-L, ASCRS post-refractive online calculator), and have a slightly higher residual refractive error rate. The decision depends on the corneal regularity on Pentacam HR (post-LASIK ectasia is a contra-indication), the macula and the patient's expectations. Intra-operative aberrometry (ORA, Cassini Ambient) is routinely used in post-LASIK PanOptix Pro cases.

When can I drive after PanOptix Pro?

Most patients drive within 1 week of bilateral PanOptix Pro surgery, once the operated eye has stabilised and the second eye is operated. The DVLA standard is binocular Snellen 6/12 with both eyes open and a horizontal visual field of at least 120 degrees. Your consultant signs off driving at the 1- or 2-week review.

Methodology and sources

This UK 2026 patient pricing and pathway guide was prepared by the Eye Surgery Clinic editorial team and reviewed by a UK GMC-registered consultant ophthalmologist with cataract and refractive subspecialty interest. Pricing reflects a CQC-registered UK premium IOL sample audited against published 2024 to 2026 self-pay tariffs from the major UK cataract and refractive providers. Clinical statements are anchored on:

• Alcon AcrySof IQ PanOptix FDA pivotal trial and post-market data
• Alcon Clareon PanOptix Pro evaluation (Clareon material, updated chromophore, ENLIGHTEN diffractive optic)
• ESCRS Functional Vision Working Group statements on trifocal and EDOF IOLs
• Royal College of Ophthalmologists Cataract Surgery Guidelines 2023
• NICE NG77 Cataracts in Adults: Management (2017, updates)
• UKISCRS National Ophthalmology Database (NOD) cataract audit
• American Academy of Ophthalmology Cataract in the Adult Eye Preferred Practice Pattern
• FACT trial of femtosecond laser-assisted cataract surgery (Day AC et al., Ophthalmology 2020)
• Barrett Universal II / Barrett Toric / Hill-RBF 3.0 / Kane / EVO 2.0 IOL formula validation studies
• Care Quality Commission (CQC) inspection reports for major UK cataract and refractive units
• General Medical Council (GMC) Good Medical Practice and consent guidance

This page is editorial and educational. It is not personalised medical advice. PanOptix Pro suitability can only be confirmed by an in-person cataract and refractive consultation with a full ocular work-up.

Book your UK PanOptix Pro consultation

Speak directly to a UK GMC-registered consultant ophthalmologist with cataract and refractive subspecialty interest. Same-week consultation slots are usually available. Slit-lamp, IOLMaster 700 Total Keratometry biometry, Pentacam HR Scheimpflug tomography, OCT macula and angle kappa / alpha measurement included. Confidential, no-obligation review of whether PanOptix Pro, PanOptix Pro Toric, Vivity, Symfony OptiBlue or an aspheric monofocal is right for you.

Related reading: Private cataract surgery cost UK · Clareon Vivity EDOF IOL UK · Toric IOL for astigmatism UK · Refractive lens exchange UK